<HTML><HEAD><TITLE>Maroteaux-Lamy syndrome</TITLE>
<META NAME="GENERATOR" CONTENT="Microsoft FrontPage 6.0"></HEAD>
<BODY BACKGROUND="Graphics/Cheetah.jpg">

<p><font size="5" color="#FF00FF"><b>Maroteaux-Lamy syndrome</b></font></p>
<p><font size="4" face="Times New Roman" color="#0000FF">* </font>
<font face="Times New Roman" color="#CC3300" size="4">&#272;&#7883;nh ngh&#297;a</font><font size="4" face="Times New Roman" color="#0000FF">:</font></p>
<blockquote>
	<p><font color="#0000FF" size="4">+ H&#7897;i ch&#7913;ng Maroteaux - Lamy</font></p>
	<p><font size="4" color="#0000FF">+ Là m&#7897;t r&#7889;i lo&#7841;n di truy&#7873;n hi&#7871;m g&#7863;p, 
	kho&#7843;ng 1/100.000 ng&#432;&#7901;i x&#7843;y ra do không có enzyme (arylsulfatese B) mà bình 
	th&#432;&#7901;ng nó xúc tác cho vi&#7879;c b&#7869; gãy </font><span class="fvMainBody">
	<font size="4" color="#0000FF">mucopolysaccharides dermatan sulfate. Nh&#7919;ng 
	mucopolysaccharides này c&#7845;u t&#7841;o nên m&#7885;i lo&#7841;i mô tr</font><font size="4" color="#0000FF">ong 
	c&#417; th&#7875; vì th&#7871; r&#7889;i lo&#7841;n này gây nên nh&#7919;ng b&#7879;nh lý ti&#7871;n tri&#7875;n và ngay c&#7843; t&#7917; 
	vong. B&#7879;nh này l&#7847;n &#273;&#7847;u tiên &#273;&#432;&#7907;c mô t&#7843; b&#7903;i&nbsp; Dr. Maroteaux and Dr. Lamy 
	n&#259;m 1963 t&#7841;i Pháp.</font></span></p>
	<p align="center">
	<img border="0" src="Images/syndrome%20images/Maroteaux_Lamy1.jpg" width="372" height="444"></p>
	<p><span class="fvMainBody"><font size="4" color="#0000FF">+ Nh&#7919;ng &#273;&#7913;a tr&#7867; 
	m&#7855;c h&#7897;i ch&#7913;ng này phát tri&#7875;n bình th&#432;&#7901;ng trong nh&#7919;ng n&#259;m &#273;&#7847;u, nh&#432;ng k&#7875; t&#7915; 
	khi nh&#7919;ng mucopolysaccharides tham gia vào vi&#7879;c t&#7841;o mô, t&#7893; ch&#7913;c thì h&#7897;i 
	ch&#7913;ng b&#7855;t &#273;&#7847;u xu&#7845;t hi&#7879;n vào n&#259;m th&#7913; 3. &#272;&#7863;c tính chính là nh&#7919;ng v&#7845;n &#273;&#7873; v&#7873; h&#7879; 
	x&#432;&#417;ng và tim.</font></span></p>
	<p><span class="fvMainBody"><font size="4" color="#0000FF">+ Không gi&#7889;ng nh&#432; 
	nh&#7919;ng h&#7897;i ch&#7913;ng khác liên quan &#273;&#7871;n Mucopolysaccharidosis, tr&#7867; em v&#7899;i h&#7897;i 
	ch&#7913;ng Maroteaux-Lamy không bi&#7875;u hi&#7879;n ch&#7853;m phát tri&#7875;n trí tu&#7879;, h&#7847;u h&#7871;t b&#7879;nh 
	nhân có trí não bình th&#432;&#7901;ng. Nh&#7919;ng tri&#7879;u ch&#7913;ng v&#7873; thân th&#7875; bao g&#7891;m: khuôn 
	m&#7863;t thô, môi và m&#361;i to, ng&#432;&#7901;i lùn (Dwarfism) và d&#7883; d&#7841;ng tay. B&#7879;nh nhân c&#361;ng 
	có v&#7845;n &#273;&#7873; th&#7883; giác do m&#7901; &#273;&#7909;c giác m&#7841;c và v&#7845;n &#273;&#7873; tim m&#7841;ch n&#7863;ng (h&#7865;p &#273;&#7897;ng m&#7841;ch 
	vành và dày van tim). H&#7847;u h&#7871;t b&#7879;nh nhân b&#7883; suy tim vào &#273;&#7897; tu&#7893;i 10=25.</font></span></p>
</blockquote>
<p><span class="fvMainBody"><font size="4" color="#CC3300">+ &#272;&#7885;c thêm:
	</font></span></p>
<blockquote>
	<span class="fvMainBody">
	<p><font size="4" color="#0000FF">Affecting one in 100,000 people, 
	Maroteaux-Lamy syndrome is a rare genetic disorder where the enzyme 
	(arylsulfatase B), which normally breaks down the mucopolysaccharides 
	dermatan sulfate, is missing.&nbsp;These mucopolysaccharides build up in all 
	tissues in the body causing progressive deterioration and eventual 
	death.&nbsp;The disease was first described in 1963 in France by Dr. Maroteaux 
	and Dr. Lamy.</font></p>
	<p><font size="4" color="#0000FF">Maroteaux-Lamy syndrome babies develop 
	normally during the first two years, but as the mucopolysaccharides start to 
	build up, the symptoms begin to appear in the third year of life.&nbsp;The major 
	features of this disease are skeletal and cardiac problems.&nbsp;Unlike many of 
	the other forms of mucopolysaccharidosis, Maroteaux-Lamy children do not 
	experience any mental retardation; most patients have a normal 
	intelligence.&nbsp;Physical manifestations of the disease include coarse-featured 
	faces, thick nostrils and lips, dwarfism, and claw hand 
	deformities.&nbsp;Patients also have vision problems (due to clouded corneas), 
	and severe heart problems (as the coronary artery narrows and the heart 
	valves thicken).&nbsp;Other symptoms may include carpal tunnel syndrome, 
	curvature of the spine, frequent runny nose, groin hernias, and hearing 
	loss.&nbsp;Most patients die of heart failure between ages 10 and 25.</font></p>
	<p><font size="4" color="#0000FF">Because Maroteaux-Lamy syndrome is 
	genetic, it is difficult to cure. Current approaches to Maroteaux-Lamy 
	include genetic counseling for parents who are carriers of the disease, and 
	improvements in early detection of the disease in unborn children 
	(Maroteaux-Lamy can be detected with amniocentesis early in the second 
	trimester).</font></p>
	<p><font size="4" color="#0000FF">For Maroteaux-Lamy patients, a variety of 
	treatments have been tried.&nbsp;The goal of treatment is to get the missing 
	enzyme into the body. nfortunately, directly injecting arylsulfatase B into 
	the bloodstream has proven unsuccessful, since the enzyme cannot make it 
	from there to the brain.&nbsp;Injecting arylsulfatase B directly into the brain 
	has not worked either, because not enough of the enzyme is absorbed.</font></p>
	<p><font size="4" color="#0000FF">To introduce arylsulfatase B into the 
	body, both gene therapy and BMT are being used in clinical trials.&nbsp;In gene 
	therapy, researchers use a virus to place the gene that produces 
	arylsulfatase B into the patient’s cells.&nbsp;BMT is used to replace in the body 
	bone marrow cells with the correct gene.&nbsp; These marrow cells are able to 
	travel to the brain much easier.&nbsp;BMT is still an experimental treatment, but 
	post-transplant patients do not suffer cardiac deterioration, and the 
	accumulated mucopolysaccharides in the liver, lungs, and marrow slowly 
	disappears.&nbsp;Vision and hearing generally improve post-transplant, as 
	well.&nbsp;Further surgery is required to correct the skeletal problems (carpal 
	tunnel surgery, for example).</font></p>
	</span>
</blockquote></BODY></HTML>